PY

Pardeep Yadav

Active Director Director DIN 10983299
DIN 10983299 First appointment Mar 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value •••• Premium profile

About Pardeep Yadav

Data last updated:

Pardeep Yadav is a Director at Impileo Lifescience Private Limited (since 2025). The company operates in Pharma. Impileo Lifescience Private Limited reported revenue of ₹6.07 Cr (FY 2025).

DIN 10983299
Primary Designation Director
Industry Pharma
First Appointment 07 Mar 2025
Oldest Company Age 5 yrs
Largest company Impileo Lifescience Private Limited · ₹6.07 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Impileo Lifescience Private Limited U24230HR2021PTC095822
Director07 Mar 20252021₹6.07 Cr (FY 2025)Active

Board colleagues of Pardeep Yadav

Directorship timeline

Open interactive timeline →
Impileo Lifescience Private Limited
Premium access

Shareholding and investment profile for Pardeep Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pardeep Yadav

Pardeep Yadav currently holds 1 directorship: Impileo Lifescience Private Limited (Director, since 07 Mar 2025, revenue ₹6.07 Cr (FY 2025)).

Pardeep Yadav was first appointed on 07 Mar 2025 as Director at Impileo Lifescience Private Limited.

The current boards of Pardeep Yadav's companies include Ashu Singla (Impileo Lifescience Private Limited), Bhanu Priya (Impileo Lifescience Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available